Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report

We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Patwari, Anannya, Bhatlapenumarthi, Vineel, Pascual, Sheila K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506375/
https://www.ncbi.nlm.nih.gov/pubmed/32999665
http://dx.doi.org/10.1159/000509640
_version_ 1783585004080594944
author Patwari, Anannya
Bhatlapenumarthi, Vineel
Pascual, Sheila K.
author_facet Patwari, Anannya
Bhatlapenumarthi, Vineel
Pascual, Sheila K.
author_sort Patwari, Anannya
collection PubMed
description We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase inhibitor cabozantinib, was brought into the emergency room because of confusion and seizures, found to have elevated blood pressure and atypical MRI findings consistent with PRES due to cabozantinib.
format Online
Article
Text
id pubmed-7506375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-75063752020-09-29 Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report Patwari, Anannya Bhatlapenumarthi, Vineel Pascual, Sheila K. Case Rep Oncol Case Report We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase inhibitor cabozantinib, was brought into the emergency room because of confusion and seizures, found to have elevated blood pressure and atypical MRI findings consistent with PRES due to cabozantinib. S. Karger AG 2020-08-21 /pmc/articles/PMC7506375/ /pubmed/32999665 http://dx.doi.org/10.1159/000509640 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Patwari, Anannya
Bhatlapenumarthi, Vineel
Pascual, Sheila K.
Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title_full Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title_fullStr Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title_full_unstemmed Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title_short Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
title_sort atypical posterior reversible encephalopathy syndrome due to oral tyrosine kinase inhibitor cabozantinib: first case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506375/
https://www.ncbi.nlm.nih.gov/pubmed/32999665
http://dx.doi.org/10.1159/000509640
work_keys_str_mv AT patwarianannya atypicalposteriorreversibleencephalopathysyndromeduetooraltyrosinekinaseinhibitorcabozantinibfirstcasereport
AT bhatlapenumarthivineel atypicalposteriorreversibleencephalopathysyndromeduetooraltyrosinekinaseinhibitorcabozantinibfirstcasereport
AT pascualsheilak atypicalposteriorreversibleencephalopathysyndromeduetooraltyrosinekinaseinhibitorcabozantinibfirstcasereport

Ejemplares similares